WYC-210 |
| カタログ番号GC60386 |
タザロテン誘導体である WYC-210 は、抗がん活性が低いレチノイド化合物です。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2131803-93-3
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
WYC-210, a Tazarotene derivative, is a retinoid compound with lower anticancer activity[1].
WYC-210 (10 μM; 5 days) inhibits cell growth of B16-F1 TRC cells with an inhibition rate of 18.1%[1].
[1]. Cao, Xin, et al. Preparation of the retinoid compound and their application as anticancer agents. WO2017152725A1.
Review for WYC-210
Average Rating: 5 (Based on Reviews and 33 reference(s) in Google Scholar.)
Review for WYC-210
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *